Seeking Alpha

KarinCA's  Instablog

KarinCA
Send Message
I'm an independent writer/trader/investor whose primary interests are in the stem cell and biotech arena. My secondary interest is in oil/energy speculation. I do venture elsewhere at times. There’s an option to follow me at the top of any article I write. Click it and you’ll also see an option... More
  • $CUR - Neuralstem Phase I Confirmed Safety And Phase II Update 2 comments
    Apr 10, 2014 1:42 PM | about stocks: CUR

    Presentation by Eva Feldman, PhD, MD, NSI-566/ALS Principal Investigator, Keystone Symposia, 4/9/14

    http://bit.ly/R6rmoj

    Slide #26 states:

    Phase 1 Trial Confirmed Safety and
    Phase 2 Trial is Underway

    • Numbers are small but data suggest that transplantation in
    subjects early in the disease course with no bulbar signs carries
    less risk
    • Phase 2: 11 subjects entered, all cervical injections
    • 1-3 (NYSE:A): 5 bilateral inj; 200,000 cells/inj: 2 million cells
    • 4-6 (NYSE:B): 10 inj/side: 200,000 cells/inj: 4 million cells
    • 7-9 (NYSE:C): 10 inj/side: 300,000 cells/inj: 6 million cells
    • 10-11 (NYSE:D): 10 inj/side: 400,000 cells/inj: 8 million cells
    • Final cohort receives bilateral cervical (8 million) followed by
    bilateral lumbar (8 million) injections for 16 million cells

    No safety concerns; subjects doing well

    Disclosure: I am long CUR.

Back To KarinCA's Instablog HomePage »

Instablogs are blogs which are instantly set up and networked within the Seeking Alpha community. Instablog posts are not selected, edited or screened by Seeking Alpha editors, in contrast to contributors' articles.

Comments (2)
Track new comments
  • TimeOnTarget
    , contributor
    Comments (2902) | Send Message
     
    Thanks for the update and link. I don't see anything that strikes me as bad, so I am guessing the sell off today is just on biotech sentiment generally????
    10 Apr 2014, 02:57 PM Reply Like
  • KarinCA
    , contributor
    Comments (390) | Send Message
     
    Author’s reply » Typical sell on the news is my guess. Couple that with general biotech sentiment.

     

    April's ALS blog is very interesting to me since ALS patients never show improvement.

     

    http://bit.ly/1ltf6YS
    11 Apr 2014, 05:13 AM Reply Like
Full index of posts »
Latest Followers

StockTalks

  • http://bit.ly/1C2uQvr
    Jan 20, 2015
  • $CTIX Reports Spleen Lesion 'Disappears' in Patient With Metastatic Stage 4 Ovarian Cancer in Clinical Trial of Anti-Cancer Drug Kevetrin
    Jan 20, 2015
  • $CTIX Confidence Interval Statistics Showing Clinical Success Rates for Brilacidin in Treatment of ABSSSI http://bit.ly/1F9XA98
    Jan 5, 2015
More »

Latest Comments


Posts by Themes
Instablogs are Seeking Alpha's free blogging platform customized for finance, with instant set up and exposure to millions of readers interested in the financial markets. Publish your own instablog in minutes.